Jose Montoya

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: SanfordHealthCare

Jose Montoya is an Infectious disease doctor and Professor of Medicine (Infectious Diseases and Geographic Medicine) at Stanford University Medical Center and heads the Stanford ME/CFS Initiative. His special areas of clinical focus include: Chronic Fatigue Syndrome, Infectious Disease, Toxoplasmosis, Infection in the setting of solid organ transplantation, and Infection as a trigger of chronic diseases.[1]

Dr. Montoya is a member of the Working Group which offers their expertise and resources to the ME/CFS Collaborative Research Center at Stanford University.[2]

Education[edit | edit source]

  • 1994, Fellowship:Stanford University School of Medicine,California, USA[1]
  • 1990, Residency:Tulane University School of Medicine, Louisiana, USA[1]
  • 1988, Internship:Tulane University School of Medicine[1]
  • 1985, Medical Education:Universidad Del Valle, Colombia[1]

Clinical practice[edit | edit source]

Dr. Montoya and his team at the Stanford ME/CFS Initiative have short term goals of Patient Care, Research and Discovery, and Education. They, also, have a long term goal of establishing an inpatient center, apart from a hospital where patients with chronic conditions could receive long-term treatment.

At present there is a waiting list to see Dr. Montoya. If you would like to be placed on the waiting list, please contact the New Patient Coordinator at (650) 736-5200.

Clinic address[edit | edit source]

2nd Floor of Hoover Pavilion, 211 Quarry Road, Palo Alto, CA 94304. Phone: (650) 736-5200.

Awards[edit | edit source]

  • 2016, Infectious Disease Specialist Jose G. Montoya, MD, to be Recognized as a 2016 Top Doctor in Stanford, California
  • 2013, Selected as one of the 100 Colombians who have exceled abroad, 2013 Edition., 100 Colombianos en el exterior[1]
  • 2011, Fellow of the American College of Physicians (FACP), American College of Physicians[1]
  • 2011, Fellow of the Infectious Diseases Society of America (FIDSA), Infectious Diseases Society of America[1]
  • 2011, The Arthur L. Bloomfield Award for Excellence in the Teaching of Clinical Medicine, Stanford University School of Medicine[1]
  • 2003, Chief Residents Teaching Award for exemplary teaching at Stanford Resident's report, Department of Medicine, Stanford University School of Medicine[1]
  • 2002, The Kenneth Vosti Teaching Award for Excellence in Teaching, Division of Infectious Diseases, Department of Medicine, Stanford University School of Medicine[1]
  • 2001, The David A. Rytand Teaching Award for Excellence in Clinical Teaching., Department of Medicine, Stanford University School of Medicine[1]
  • 2000, The Kenneth Vosti Teaching Award for Excellence in Teaching, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine[1]
  • 1998, The David A. Rytand Teaching Award for Excellence in Clinical Teaching, Department of Medicine, Stanford University School of Medicine[1]
  • 1997, The Arthur L. Bloomfield Award for Excellence in the Teaching of Clinical Medicine, Stanford University School of Medicine[1]
  • 1995, The Henry J. Kaiser Award for Excellence in Clinical Teaching, Stanford University School of Medicine[1]
  • 1995, The Franklin G. Ebaugh, Jr. Award for Advising Medical Students, Stanford University School of Medicine [1]
  • 1990, Outstanding Senior Resident Awar, Department of Medicine, Tulane University School of Medicine[1]
  • 1990, The Department of Medicine Outstanding Teaching Award, Tulane University School of Medicine[1]
  • 1990, The Owl Club Award for Outstanding Clinical Teaching, Tulane University School of Medicine[1]
  • 1988, Outstanding Intern Award, Department of Medicine, Tulane University School of Medicine[1]

IOM Committee on Diagnostic Criteria for ME/CFS[edit | edit source]

Dr Montoya was a reviewer for the 2015 report produced by the Institute of Medicine's Committee on Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.[3]

Notable Studies[edit | edit source]

Talks & Interviews[edit | edit source]

Notable quotes[edit | edit source]

Back in 2005, while attending a conference on toxoplasmosis in Paris, Montoya told his mentor that he wanted to research ME/CFS. His mentor scoffed at the idea, pointing to a homeless person lying in a Parisian gutter. 'That’s going to be you if you go into chronic fatigue research,' the mentor told him.[17]

Online presence[edit | edit source]

Learn more[edit | edit source]

See also[edit | edit source]

References[edit | edit source]

  1. 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 1.10 1.11 1.12 1.13 1.14 1.15 1.16 1.17 1.18 1.19 1.20 Montoya, Jose G., Stanford Medicine Bio 
  2. https://bos.etapestry.com/prod/viewEmailAsPage.do?erRef=773.0.423082047&databaseId=OMF&mailingId=34274682&jobRef=773.0.506425459&key=b6b9237b3ebd1e462a5d11dbc5c4dae&personaRef=773.0.423082048&memberId=1348639685
  3. https://www.nap.edu/resource/19012/MECFS_Powerpoint.pdf
  4. Moneghetti, Kegan J.; Skhiri, Mehdi; Contrepois, Kévin; Kobayashi, Yukari; Maecker, Holden T.; Davis, Mark M.; Snyder, Michael; Haddad, Francois; Montoya, Jose G. (2018), "Value of Circulating Cytokine Profiling During Submaximal Exercise Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome", Scientific Reports, 8, doi:10.1038/s41598-018-20941-w 
  5. Montoya, Jose G; Anderson, Jill N; Adolphs, Danya L; Bateman, Lucinda; Klimas, Nancy; Levine, Susan M; Garvert, Donn W; Kaiser, Jon D (2018), "KPAX002 as a treatment for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A prospective, randomized trial" (PDF), International Journal of Clinical and Experimental Medicine, 11 (3): 2890-2900 
  6. Montoya, Jose G.; Holmes, Tyson H.; Anderson, Jill N.; Maecker, Holden T.; Rosenberg-Hasson, Yael; Valencia, Ian J.; Chu, Lily; Younger, Jarred W.; Tato, Cristina M.; Davis, Mark M. (2017), "Cytokine signature associated with disease severity in chronic fatigue syndrome patients", Proceedings of the National Academy of Sciences of the United States of America, 114 (34): E7150-E7158, doi:10.1073/pnas.1710519114 
  7. Chu, Lily; Norris, Jane; Valencia, Ian J.; Montoya, Jose G. (2017), "Patients diagnosed with Myalgic encephalomyelitis/chronic fatigue syndrome also fit systemic exertion intolerance disease criteria", Fatigue: Biomedicine, Health & Behavior, 5, doi:10.1080/21641846.2017.1299079 
  8. Nagy-Szakal, Dorottya; Williams, Brent L.; Mishra, Nischay; Che, Xiaoyu; Lee, Bohyun; Bateman, Lucinda; Klimas, Nancy G.; Komaroff, Anthony L.; Levine, Susan; Montoya, Jose G.; Peterson, Daniel L.; Ramanan, Devi; Jain, Komal; Eddy, Meredith L.; Hornig, Mady; Lipkin, W. Ian (2017), "Fecal metagenomic profiles in subgroups of patients with myalgic encephalomyelitis/chronic fatigue syndrome", Microbiome, 5 (44), doi:10.1186/s40168-017-0261-y 
  9. Zeineh, Michael M.; Kang, James; Atlas, Scott W.; Raman, Mira M.; Reiss, Allan L.; Norris, Jane L.; Valencia, Ian; Montoya, Jose G. (Feb 2015), "Right Arcuate Fasciculus Abnormality in Chronic Fatigue Syndrome" (PDF), Radiology, 274 (2): 517-526, doi:10.1148/radiol.14141079 
  10. Hornig, M; Montoya, JG; Klimas, NG; Levine, SM; Felsenstein, D; Bateman, L; Peterson, DL; Gottschalk, CG; Schultz, AF; Che, X; Eddy, ML; Komaroff, AL; Lipkin, WI (2015), "Distinct plasma immune signatures in ME/CFS are present early in the course of illness", Science Advances, 1 (1), doi:10.1126/sciadv.1400121 
  11. Zinn, Marcie L; Zinn, Mark A; Norris, Jane; Valencia, Ian; Montoya, Jose G; Maldonad, Jose R (2014), "EEG peak alpha frequency is associated with chronic fatigue syndrome: A case-control observational study", Conference: 2014 Stanford Myalgic Encephalomyelitis/ Chronic Fatigue Syndrome Symposium 
  12. Zinn, Mark & Zinn, Marcie & L. Norris, Jane & Valencia, Ian & Montoya, Jose & R. Maldonado, J. (2014). Cortical hypoactivation during resting eLORETA suggests central nervous system pathology in patients with chronic fatigue syndrome.
  13. Stringer, Elizabeth Ann; Baker, Katharine Susanne; Carroll, Ian R; Montoya, Jose G; Chu, Lily; Maecker, Holden T; Younger, Jarred W (9 April 2013), "Daily cytokine fluctuations, driven by leptin, are associated with fatigue severity in chronic fatigue syndrome: evidence of inflammatory pathology", Journal of Translational Medicine, 2013 (11): 93, doi:10.1186/1479-5876-11-93 
  14. Montoya, JG; Kogelnik, AM; Bhangoo, M; Lunn, MR; Flamand, L; Merrihew, LE; Watt, T; Kubo, JT; Paik, J; Desai, M (2013), "Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome.", Journal of Medical Virology, 85 (12): 2101-9, doi:10.1002/jmv.23713, PMID 23959519 
  15. Watt, T; Oberfoell, S; Balise, R; Lunn, MR; Kar, AK; Merrihew, LE; Bhangoo, MS; Montoya, JG (2012), "Response to valganciclovir in chronic fatigue syndrome patients with human herpesvirus 6 and Epstein-Barr virus IgG antibody titers", Journal of Medical Virology, 84 (12): 1967-1974, doi:10.1002/jmv.23411, PMID 23080504 
  16. Alter, Harvey J.; Mikovits, Judy A.; Switzer, William M.; Ruscetti, Francis W.; Lo, Shyh-Ching; Klimas, Nancy; Komaroff, Anthony L.; Montoya, Jose G.; Bateman, Lucinda; Levine, Susan; Peterson, Daniel; Levin, Bruce; Hanson, Maureen R.; Genfi, Afia; Bhat, Meera; Zheng, HaoQiang; Wang, Richard; Li, Bingjie; Hung, Guo-Chiuan; Lee, Li Ling; Sameroff, Stephen; Heneine, Walid; Coffin, John; Hornig, Mady; Lipkin, W. Ian (2012), "A Multicenter Blinded Analysis Indicates No Association between Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and either Xenotropic Murine Leukemia Virus-Related Virus or Polytropic Murine Leukemia Virus", mBio, 3 (5): e00266–12, doi:10.1128/mBio.00266-12 
  17. Immune System Disruption - Stanford Med


The information provided at this site is not intended to diagnose or treat any illness.

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history